{
    "status": "ok",
    "totalResults": 85,
    "articles": [
        {
            "source": {
                "id": null,
                "name": "Yahoo Entertainment"
            },
            "author": "GuruFocus Research",
            "title": "Decoding Tandem Diabetes Care Inc (TNDM)'s Performance Potential: A Deep Dive into Key Metrics",
            "description": "Unraveling the Factors That Could Limit Tandem Diabetes Care Inc's Future Growth",
            "url": "https://finance.yahoo.com/news/decoding-tandem-diabetes-care-inc-170456577.html",
            "urlToImage": "https://s.yimg.com/ny/api/res/1.2/He1Lq.APYZircj11muzeew--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05NTU-/https://media.zenfs.com/en/us.finance.gurufocus/eaafeb78f7d689b40c083ce5375da484",
            "publishedAt": "2023-09-26T17:04:56Z",
            "content": "Long-established in the Medical Devices &amp; Instruments industry, Tandem Diabetes Care Inc (NASDAQ:TNDM) has enjoyed a stellar reputation. It has recently witnessed a daily gain of 4.97%, juxtapose\u2026 [+3519 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Yahoo Entertainment"
            },
            "author": "GuruFocus Research",
            "title": "Is Tandem Diabetes Care (TNDM) Too Good to Be True? A Comprehensive Analysis of a Potential ...",
            "description": "Deciphering the Risks and Rewards of Investing in Tandem Diabetes Care",
            "url": "https://finance.yahoo.com/news/tandem-diabetes-care-tndm-too-233724899.html",
            "urlToImage": "https://media.zenfs.com/en/us.finance.gurufocus/a2a03c2764092703511946b41e8ea71f",
            "publishedAt": "2023-09-14T23:37:24Z",
            "content": "Value-focused investors are always on the hunt for stocks that are priced below their intrinsic value. One such stock that merits attention is Tandem Diabetes Care Inc (NASDAQ:TNDM). The stock, which\u2026 [+4812 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Yahoo Entertainment"
            },
            "author": "GuruFocus Research",
            "title": "Unraveling the Future of Tandem Diabetes Care Inc (TNDM): A Deep Dive into Key Metrics",
            "description": "Understanding the Factors Limiting Growth and Performance",
            "url": "https://finance.yahoo.com/news/unraveling-future-tandem-diabetes-care-160547133.html",
            "urlToImage": "https://s.yimg.com/ny/api/res/1.2/Gs2ER8dBkMvflABS7AseFw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD05NTU-/https://media.zenfs.com/en/us.finance.gurufocus/e4f243c88e0731cbe2b94af3c78348d4",
            "publishedAt": "2023-09-15T16:05:47Z",
            "content": "Long-established in the Medical Devices &amp; Instruments industry, Tandem Diabetes Care Inc (NASDAQ:TNDM) has enjoyed a stellar reputation. However, it has recently witnessed a decline of 6.15%, jux\u2026 [+3137 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Yahoo Entertainment"
            },
            "author": "Lisa Pham, Madison Muller and Naomi Kresge",
            "title": "A Stock Investor\u2019s Guide to Navigating Weight Loss Opportunities",
            "description": "(Bloomberg) -- For investors, there's a whole lot more to the boom in demand for weight-loss drugs than the rising stock prices of Novo Nordisk A/S and Eli...",
            "url": "https://finance.yahoo.com/news/stock-investor-guide-navigating-weight-073036817.html",
            "urlToImage": "https://s.yimg.com/ny/api/res/1.2/bwN9qaDCFkel3eaixhPjwA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD03MDA-/https://media.zenfs.com/en/bloomberg_markets_842/011ae6f758593eb42e58e9323488fdaf",
            "publishedAt": "2023-09-16T07:30:36Z",
            "content": "(Bloomberg) -- For investors, there's a whole lot more to the boom in demand for weight-loss drugs than the rising stock prices of Novo Nordisk A/S and Eli Lilly &amp; Co.\r\nMost Read from Bloomberg\r\n\u2026 [+9151 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit",
            "description": "(marketscreener.com) \n\nLOS ANGELES, Oct. 6, 2023 /PRNewswire/ --\u00a0Glancy Prongay & Murray LLP announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. .\n\n \n \n \n \n \n \n\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/TNDM-Investors-Have-Opportunity-to-Lead-Tandem-Diabetes-Care-Inc-Securities-Fraud-Lawsuit-45003143/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-10-06T16:01:06Z",
            "content": "LOS ANGELES, Oct. 6, 2023 /PRNewswire/ --\u00a0Glancy Prongay &amp; Murray LLP (\"GPM\") announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit a\u2026 [+2451 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "TNDM INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit",
            "description": "(marketscreener.com) \nRobbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. securities between August 3, 2022 and November 2, 2022, both dates inclusive have until November 7, 2023 to seek appointment as lead pl\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/TNDM-INVESTOR-DEADLINE-Robbins-Geller-Rudman-Dowd-LLP-Announces-that-Tandem-Diabetes-Care-Inc-I-44868517/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-09-18T15:46:02Z",
            "content": "Robbins Geller Rudman &amp; Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022, both dates inclusive (\u2026 [+4055 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Robbins LLP",
            "title": "Tandem Diabetes Care, Inc. (TNDM) Investor Alert: Robbins LLP Reminds Investors of Class Action Filed Against Tandem Diabetes Care, Inc.",
            "description": "SAN DIEGO, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Robbins LLP\u00a0reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/15/2744208/32719/en/Tandem-Diabetes-Care-Inc-TNDM-Investor-Alert-Robbins-LLP-Reminds-Investors-of-Class-Action-Filed-Against-Tandem-Diabetes-Care-Inc.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/df31ba33-ed56-4425-9937-22b42e49bdb2",
            "publishedAt": "2023-09-15T17:52:00Z",
            "content": "SAN DIEGO, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Robbins LLP\u00a0reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes Care\u2026 [+2926 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "Tandem Diabetes Care, Inc. (TNDM) Class Action Notice: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Tandem Diabetes Care, Inc. Securities Fraud Class Action",
            "description": "(marketscreener.com) \nRobbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes Care, Inc. securities between August 3, 2022 and November 2, 2022. Tandem is a global me\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/Tandem-Diabetes-Care-Inc-TNDM-Class-Action-Notice-Robbins-LLP-Reminds-Investors-of-Lead-Plainti-44869683/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-09-18T19:41:02Z",
            "content": "Robbins LLP reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between Augus\u2026 [+2971 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Robbins LLP",
            "title": "TNDM Shareholders Who Have Lost Money in the Stock Should Contact Robbins LLP for Information About the Class Action Against Tandem Diabetes Care, Inc.",
            "description": "Tandem Diabetes Care, Inc. (TNDM) Misled Investors Regarding Revenue Projections           ......",
            "url": "https://www.globenewswire.com/news-release/2023/09/28/2751431/32719/en/TNDM-Shareholders-Who-Have-Lost-Money-in-the-Stock-Should-Contact-Robbins-LLP-for-Information-About-the-Class-Action-Against-Tandem-Diabetes-Care-Inc.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/df31ba33-ed56-4425-9937-22b42e49bdb2",
            "publishedAt": "2023-09-28T15:05:00Z",
            "content": "SAN DIEGO, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Robbins LLP\u00a0reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes Care\u2026 [+2926 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Robbins LLP",
            "title": "Tandem Diabetes Care, Inc. Investors: Lead Plaintiff Deadline is Approaching in the Class Action Against Tandem Diabetes Care, Inc.; Contact Robbins LLP Today",
            "description": "Tandem Diabetes Care, Inc. (TNDM) Misled Investors Regarding Revenue Projections           ......",
            "url": "https://www.globenewswire.com/news-release/2023/10/05/2755731/32719/en/Tandem-Diabetes-Care-Inc-Investors-Lead-Plaintiff-Deadline-is-Approaching-in-the-Class-Action-Against-Tandem-Diabetes-Care-Inc-Contact-Robbins-LLP-Today.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/df31ba33-ed56-4425-9937-22b42e49bdb2",
            "publishedAt": "2023-10-05T18:59:00Z",
            "content": "SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Robbins LLP\u00a0reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes Care,\u2026 [+2925 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit",
            "description": "(marketscreener.com) \n\nLOS ANGELES, Sept. 27, 2023 /PRNewswire/ --\u00a0The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. .\n\nClass\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/TNDM-Investors-Have-Opportunity-to-Lead-Tandem-Diabetes-Care-Inc-Securities-Fraud-Lawsuit-44933883/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-27T20:14:03Z",
            "content": "LOS ANGELES, Sept. 27, 2023 /PRNewswire/ --\u00a0The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit agains\u2026 [+2177 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM",
            "description": "(marketscreener.com) \n\nNEW YORK, Sept. 29, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. . Such investors are advised to contact Robert S. Willoughby at \u00a0newaction@pomlaw.com or 888-476-6529, e\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Tandem-Diabetes-Care-Inc-TNDM-44956624/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-29T21:04:03Z",
            "content": "NEW YORK, Sept. 29, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (\"Tandem\" or the \"Company\") (NASDAQ:\u00a0TNDM). Such investors are advi\u2026 [+2001 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "ROSEN, A LONGSTANDING LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - TNDM",
            "description": "(marketscreener.com) \n\nNEW YORK, Sept. 28, 2023 /PRNewswire/ --\u00a0\n\n \n \n \n \n \n \n\n \nWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. between August 3, 2022 and November 2, 2022, both dates...h\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/ROSEN-A-LONGSTANDING-LAW-FIRM-Encourages-Tandem-Diabetes-Care-Inc-Investors-with-Losses-in-Exces-44946255/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-28T20:04:03Z",
            "content": "NEW YORK, Sept. 28, 2023 /PRNewswire/ --\u00a0\r\nWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022\u2026 [+5058 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit",
            "description": "(marketscreener.com) \n\nLOS ANGELES, Oct. 11, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. .\n\nClass \u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/TNDM-Investors-Have-Opportunity-to-Lead-Tandem-Diabetes-Care-Inc-Securities-Fraud-Lawsuit-45042050/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-10-11T16:01:05Z",
            "content": "LOS ANGELES, Oct. 11, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against\u2026 [+2174 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM",
            "description": "(marketscreener.com) \n\nNEW YORK, Sept. 13, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of\u00a0\u00a0Tandem Diabetes Care, Inc. \u00a0.\u00a0\u00a0 Such investors are advised to contact Robert S. Willoughby at \u00a0newaction@pomlaw.com or 888-476-652\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Tandem-Diabetes-Care-Inc-TNDM-44837598/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-13T21:04:04Z",
            "content": "NEW YORK, Sept. 13, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of\u00a0\u00a0Tandem Diabetes Care, Inc. (\"Tandem\" or the \"Company\")\u00a0(NASDAQ:\u00a0TNDM).\u00a0\u00a0 Such investors are a\u2026 [+2005 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM",
            "description": "(marketscreener.com) \n\nNEW YORK, Oct. 9, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. . Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext.\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Tandem-Diabetes-Care-Inc-TNDM-45022479/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-10-09T19:37:03Z",
            "content": "NEW YORK, Oct. 9, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (\"Tandem\" or the \"Company\") (NASDAQ:\u00a0TNDM). Such investors are advise\u2026 [+1996 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM",
            "description": "(marketscreener.com) \n\nNEW YORK, Sept. 21, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. . Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ex\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Tandem-Diabetes-Care-Inc-TNDM-44899789/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-09-21T21:39:03Z",
            "content": "NEW YORK, Sept. 21, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (\"Tandem\" or the \"Company\") (NASDAQ: TNDM). Such investors are advi\u2026 [+1998 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "PRNewswire",
            "title": "TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit",
            "description": "(marketscreener.com) \n\nBENSALEM, Pa., Oct. 3, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. .\n\nClass P\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/TNDM-Investors-Have-Opportunity-to-Lead-Tandem-Diabetes-Care-Inc-Securities-Fraud-Lawsuit-44972964/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-10-03T13:01:20Z",
            "content": "BENSALEM, Pa., Oct. 3, 2023 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against \u2026 [+2348 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "Law Offices of Howard G. Smith Announces Investigation of Tandem Diabetes Care, Inc. (TNDM) on Behalf of Investors",
            "description": "(marketscreener.com) \nLaw Offices of Howard G. Smith announces an investigation on behalf of Tandem Diabetes Care, Inc. investors concerning the Company\u2019s possible violations of federal securities laws.\n\n\nOn November 2, 2022, Tandem revised its 2022 financial\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/Law-Offices-of-Howard-G-Smith-Announces-Investigation-of-Tandem-Diabetes-Care-Inc-TNDM-on-Behal-44847755/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-14T20:46:01Z",
            "content": "Law Offices of Howard G. Smith announces an investigation on behalf of Tandem Diabetes Care, Inc. (Tandem or the Company) (NASDAQ: TNDM) investors concerning the Companys possible violations of feder\u2026 [+1170 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Newsfilecorp",
            "title": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TNDM",
            "description": "(marketscreener.com) WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. between August 3, 2022 and November 2, 2022, both dates inclusive , of the important November 7, 2023 lead plaintiff de\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/ROSEN-GLOBAL-INVESTOR-COUNSEL-Encourages-Tandem-Diabetes-Care-Inc-Investors-to-Secure-Counsel-Be-44975573/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-10-03T19:45:01Z",
            "content": "New York, New York--(Newsfile Corp. - October 3, 2023) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between \u2026 [+4890 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "The Law Offices of Frank R. Cruz Announces Investigation of Tandem Diabetes Care, Inc. (TNDM) on Behalf of Investors",
            "description": "(marketscreener.com) \nThe Law Offices of Frank R. Cruz announces an investigation of Tandem Diabetes Care, Inc. on behalf of investors concerning the Company\u2019s possible violations of federal securities laws.\n\n\nIf you are a shareholder who suffered a loss, cli\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/The-Law-Offices-of-Frank-R-Cruz-Announces-Investigation-of-Tandem-Diabetes-Care-Inc-TNDM-on-Beh-44836826/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-13T18:39:02Z",
            "content": "The Law Offices of Frank R. Cruz announces an investigation of Tandem Diabetes Care, Inc. (Tandem or the Company) (NASDAQ: TNDM) on behalf of investors concerning the Companys possible violations of \u2026 [+1358 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Tandem Diabetes Care, Inc. (TNDM) on Behalf of Investors",
            "description": "(marketscreener.com) \nGlancy Prongay & Murray LLP , a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Tandem Diabetes Care, Inc. investors concerning the Company\u2019s possible violations of the fe\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/Glancy-Prongay-Murray-LLP-a-Leading-Securities-Fraud-Law-Firm-Announces-Investigation-of-Tandem-44854801/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-09-15T15:01:02Z",
            "content": "Glancy Prongay &amp; Murray LLP (GPM), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Tandem Diabetes Care, Inc. (Tandem or the Co\u2026 [+3317 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": null,
            "title": "Tandem Diabetes Care to Announce Third Quarter 2023 Financial Results on November 1, 2023",
            "description": "(marketscreener.com) \nTandem Diabetes Care, Inc. , a leading insulin delivery and diabetes technology company, plans to release its third quarter 2023 results after the financial markets close on Wednesday, November 1, 2023. The Company will hold a conference\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/Tandem-Diabetes-Care-to-Announce-Third-Quarter-2023-Financial-Results-on-November-1-2023-45032446/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-10-10T20:06:03Z",
            "content": "Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, plans to release its third quarter 2023 results after the financial markets close on Wednesday, \u2026 [+1900 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Bernstein Liebhard LLP",
            "title": "TANDEM DIABETES CARE, INC. (NASDAQ: TNDM) DEADLINE ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Tandem Diabetes Care, Inc.",
            "description": "NEW YORK, Sept.  25, 2023  (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:  Do you, or did you, own shares of Tandem Diabetes Care, Inc. (NASDAQ: TNDM)?Did...",
            "url": "https://www.globenewswire.com/news-release/2023/09/25/2748910/0/en/TANDEM-DIABETES-CARE-INC-NASDAQ-TNDM-DEADLINE-ALERT-Bernstein-Liebhard-LLP-Announces-that-a-Securities-Class-Action-Lawsuit-Has-Been-Filed-Against-Tandem-Diabetes-Care-Inc.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/5d514042-8326-4555-8ad7-f6cc765ecfcd",
            "publishedAt": "2023-09-25T16:30:00Z",
            "content": "NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:\r\n<ul><li>Do you, or did you, own shares of Tandem Diabetes Care, Inc. (NASDAQ: TNDM)?</li><li>Did you purchase your shares between\u2026 [+3765 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Johnson Fistel, LLP",
            "title": "Johnson Fistel Announces a Class Action Lawsuit has been Filed Against Tandem Diabetes Care",
            "description": "SAN DIEGO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP notifies investors of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) (\u201cTandem Diabetes Care\u201d or the \u201cCompany\u201d) a securities class action lawsuit has been filed. The lawsuit seeks to recover losses o\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/25/2748805/0/en/Johnson-Fistel-Announces-a-Class-Action-Lawsuit-has-been-Filed-Against-Tandem-Diabetes-Care.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/bb2e6cf6-9d53-4d2e-a5d2-759cdd3b516c",
            "publishedAt": "2023-09-25T14:35:00Z",
            "content": "SAN DIEGO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP notifies investors of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) (Tandem Diabetes Care or the Company) a securities class action lawsu\u2026 [+2970 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Johnson Fistel, LLP",
            "title": "TNDM Shareholder Update: Johnson Fistel Encourages Tandem Diabetes Care Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline",
            "description": "SAN DIEGO, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP notifies investors of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) (\u201cTandem Diabetes Care\u201d or the \u201cCompany\u201d) a securities class action lawsuit has been filed. The lawsuit seeks to recover losses on\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/06/2756165/0/en/TNDM-Shareholder-Update-Johnson-Fistel-Encourages-Tandem-Diabetes-Care-Investors-to-Seek-Counsel-Before-Lead-Plaintiff-Class-Action-Deadline.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/bb2e6cf6-9d53-4d2e-a5d2-759cdd3b516c",
            "publishedAt": "2023-10-06T14:02:00Z",
            "content": "SAN DIEGO, Oct. 06, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP notifies investors of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) (Tandem Diabetes Care or the Company) a securities class action lawsui\u2026 [+2969 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Johnson Fistel, LLP",
            "title": "TNDM Shareholder Update: Johnson Fistel Encourages Tandem Diabetes Care Investors to Seek Counsel Before Lead Plaintiff Class Action Deadline",
            "description": "SAN DIEGO, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP notifies investors of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) (\u201cTandem Diabetes Care\u201d or the \u201cCompany\u201d) a securities class action lawsuit has been filed. The lawsuit seeks to recover losses on\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/13/2760010/0/en/TNDM-Shareholder-Update-Johnson-Fistel-Encourages-Tandem-Diabetes-Care-Investors-to-Seek-Counsel-Before-Lead-Plaintiff-Class-Action-Deadline.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/bb2e6cf6-9d53-4d2e-a5d2-759cdd3b516c",
            "publishedAt": "2023-10-13T13:48:00Z",
            "content": "SAN DIEGO, Oct. 13, 2023 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP notifies investors of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) (Tandem Diabetes Care or the Company) a securities class action lawsui\u2026 [+2969 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors",
            "description": "(marketscreener.com) \nLaw Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Tandem Diabetes Care, Inc. securities between August 3, 20222 and November 2, 2022, inclusive . Tandem investors hav\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/Law-Offices-of-Howard-G-Smith-Announces-the-Filing-of-a-Securities-Class-Action-on-Behalf-of-Tandem-44867523/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-18T13:31:01Z",
            "content": "Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Tandem Diabetes Care, Inc. (Tandem or the Company) (NASDAQ: TNDM) securities b\u2026 [+2562 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Bernstein Liebhard LLP",
            "title": "DEADLINE ALERT: Bernstein Liebhard LLP Reminds Tandem Diabetes Care, Inc. Investors of Upcoming Deadline",
            "description": "NEW YORK, Oct.  03, 2023  (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:  Do you, or did you, own shares of Tandem Diabetes Care, Inc. (NASDAQ: TNDM)?Did...",
            "url": "https://www.globenewswire.com/news-release/2023/10/03/2753282/0/en/DEADLINE-ALERT-Bernstein-Liebhard-LLP-Reminds-Tandem-Diabetes-Care-Inc-Investors-of-Upcoming-Deadline.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/5d514042-8326-4555-8ad7-f6cc765ecfcd",
            "publishedAt": "2023-10-03T05:45:00Z",
            "content": "NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP:\r\n<ul><li>Do you, or did you, own shares of Tandem Diabetes Care, Inc. (NASDAQ: TNDM)?</li><li>Did you purchase your shares between \u2026 [+2290 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Robbins LLP",
            "title": "TNDM Shareholder Alert: Investors with Large Losses Should Contact Robbins LLP for Information About Recovery Against Tandem Diabetes Care, Inc.",
            "description": "SAN DIEGO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Robbins LLP\u00a0reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/21/2747722/32719/en/TNDM-Shareholder-Alert-Investors-with-Large-Losses-Should-Contact-Robbins-LLP-for-Information-About-Recovery-Against-Tandem-Diabetes-Care-Inc.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/df31ba33-ed56-4425-9937-22b42e49bdb2",
            "publishedAt": "2023-09-21T22:52:00Z",
            "content": "SAN DIEGO, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Robbins LLP\u00a0reminds investors that a shareholder filed a class action on behalf of all investors who purchased or otherwise acquired Tandem Diabetes Care\u2026 [+2921 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors",
            "description": "(marketscreener.com) \nThe Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Tandem Diabetes Care, Inc. securities between August 3, 2022 and November 2, 202\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/The-Law-Offices-of-Frank-R-Cruz-Announces-the-Filing-of-a-Securities-Class-Action-on-Behalf-of-Tand-44869116/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-18T17:06:01Z",
            "content": "The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Tandem Diabetes Care, Inc. (Tandem or the \u2026 [+2881 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)",
            "description": "(marketscreener.com) \nLaw Offices of Howard G. Smith reminds investors of the upcoming November 7, 2023 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Tandem Diabetes Care, Inc. securities between August 3, 202\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/Deadline-Reminder-Law-Offices-of-Howard-G-Smith-Reminds-Investors-of-Looming-Deadline-in-the-Class-44896354/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-21T13:10:01Z",
            "content": "Law Offices of Howard G. Smith reminds investors of the upcoming November 7, 2023 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Tandem Diabetes Care,\u2026 [+2907 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)",
            "description": "(marketscreener.com) \nGlancy Prongay & Murray LLP reminds investors of the upcoming November 7, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Tandem Diabetes Care, Inc. secur\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/Glancy-Prongay-Murray-LLP-Reminds-Investors-of-Looming-Deadline-in-the-Class-Action-Lawsuit-Agains-44906835/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdnoir.png",
            "publishedAt": "2023-09-22T16:50:02Z",
            "content": "Glancy Prongay &amp; Murray LLP (GPM) reminds investors of the upcoming November 7, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or oth\u2026 [+3268 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Tandem Diabetes Care, Inc. (TNDM) Investors",
            "description": "(marketscreener.com) \nGlancy Prongay & Murray LLP , a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Tandem Diabetes Care, Inc. securities between A\u2026",
            "url": "https://www.marketscreener.com/quote/stock/TANDEM-DIABETES-CARE-INC-38066231/news/Glancy-Prongay-Murray-LLP-a-Leading-Securities-Fraud-Law-Firm-Announces-the-Filing-of-a-Securiti-44878362/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-09-19T17:13:01Z",
            "content": "Glancy Prongay &amp; Murray LLP (GPM), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired \u2026 [+3260 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Glancy Prongay & Murray LLP",
            "title": "Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)",
            "description": "LOS ANGELES, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (\u201cGPM\u201d) reminds investors of the upcoming\u00a0November 7, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquire\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/25/2748828/34548/en/Glancy-Prongay-Murray-LLP-Reminds-Investors-of-Looming-Deadline-in-the-Class-Action-Lawsuit-Against-Tandem-Diabetes-Care-Inc-TNDM.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/dca1d463-f40e-41ea-a1d6-f8a47b633445",
            "publishedAt": "2023-09-25T15:00:00Z",
            "content": "LOS ANGELES, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay &amp; Murray LLP (GPM) reminds investors of the upcoming\u00a0November 7, 2023 deadline to file a lead plaintiff motion in the class action f\u2026 [+3360 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Glancy Prongay & Murray LLP",
            "title": "Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)",
            "description": "LOS ANGELES, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (\u201cGPM\u201d) reminds investors of the upcoming\u00a0November 7, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/09/2756884/34548/en/Glancy-Prongay-Murray-LLP-Reminds-Investors-of-Looming-Deadline-in-the-Class-Action-Lawsuit-Against-Tandem-Diabetes-Care-Inc-TNDM.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/dca1d463-f40e-41ea-a1d6-f8a47b633445",
            "publishedAt": "2023-10-09T16:00:00Z",
            "content": "LOS ANGELES, Oct. 09, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay &amp; Murray LLP (GPM) reminds investors of the upcoming\u00a0November 7, 2023 deadline to file a lead plaintiff motion in the class action fi\u2026 [+3359 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Glancy Prongay & Murray LLP",
            "title": "Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Tandem Diabetes Care, Inc. (TNDM)",
            "description": "LOS ANGELES, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (\u201cGPM\u201d) reminds investors of the upcoming\u00a0November 7, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/02/2753075/34548/en/Glancy-Prongay-Murray-LLP-Reminds-Investors-of-Looming-Deadline-in-the-Class-Action-Lawsuit-Against-Tandem-Diabetes-Care-Inc-TNDM.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/dca1d463-f40e-41ea-a1d6-f8a47b633445",
            "publishedAt": "2023-10-02T17:02:00Z",
            "content": "LOS ANGELES, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay &amp; Murray LLP (GPM) reminds investors of the upcoming\u00a0November 7, 2023 deadline to file a lead plaintiff motion in the class action fi\u2026 [+3359 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Pomerantz LLP",
            "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims\u00a0On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM",
            "description": "NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (\u201cTandem\u201d or the \u201cCompany\u201d) (NASDAQ:\u00a0TNDM). Such investors are advised to contact Robert S. Willoughby at \u00a0newaction@pomlaw.\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/11/2758635/1087/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Tandem-Diabetes-Care-Inc-TNDM.html",
            "urlToImage": null,
            "publishedAt": "2023-10-11T15:47:00Z",
            "content": "NEW YORK, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (Tandem or the Company) (NASDAQ:\u00a0TNDM). Such investors are advis\u2026 [+1767 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Pomerantz LLP",
            "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM",
            "description": "NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (\u201cTandem\u201d or the \u201cCompany\u201d) (NASDAQ:\u00a0TNDM).\u00a0\u00a0 Such investors are advised to contact Robert S. Willoughby at \u00a0newaction@poml\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/25/2749066/1087/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Tandem-Diabetes-Care-Inc-TNDM.html",
            "urlToImage": null,
            "publishedAt": "2023-09-25T22:47:00Z",
            "content": "NEW YORK, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (Tandem or the Company) (NASDAQ:\u00a0TNDM).\u00a0\u00a0 Such investors are ad\u2026 [+1768 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Pomerantz LLP",
            "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims\u00a0On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM",
            "description": "NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (\u201cTandem\u201d or the \u201cCompany\u201d) (NASDAQ:\u00a0TNDM).\u00a0 Such investors are advised to contact Robert S. Willoughby at \u00a0newaction@pomlaw\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/03/2754014/1087/en/SHAREHOLDER-ALERT-Pomerantz-Law-Firm-Investigates-Claims-On-Behalf-of-Investors-of-Tandem-Diabetes-Care-Inc-TNDM.html",
            "urlToImage": null,
            "publishedAt": "2023-10-03T16:45:00Z",
            "content": "NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (Tandem or the Company) (NASDAQ:\u00a0TNDM).\u00a0 Such investors are advi\u2026 [+1766 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Lifshitz Law Firm, P.C.",
            "title": "Lifshitz Law PLLC Announces Investigations of UiPath, Inc. (NYSE: PATH), Tandem Diabetes Care, Inc. (NASDAQ: TNDM), Leslie\u2019s, Inc. (NASDAQ: LESL), and PacWest Bancorp (NASDAQ: PACW)",
            "description": "NEW YORK, Sept.  30, 2023  (GLOBE NEWSWIRE) --   UiPath, Inc. (NYSE: PATH)  Lifshitz Law PLLC announces investigation into possible securities laws......",
            "url": "https://www.globenewswire.com/news-release/2023/09/30/2752373/0/en/Lifshitz-Law-PLLC-Announces-Investigations-of-UiPath-Inc-NYSE-PATH-Tandem-Diabetes-Care-Inc-NASDAQ-TNDM-Leslie-s-Inc-NASDAQ-LESL-and-PacWest-Bancorp-NASDAQ-PACW.html",
            "urlToImage": null,
            "publishedAt": "2023-09-30T23:00:00Z",
            "content": "NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) -- \r\nUiPath, Inc. (NYSE: PATH)\r\nLifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in con\u2026 [+4992 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Bragar Eagel & Squire",
            "title": "Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UiPath, Tandem, and Leslie\u2019s and Encourages Investors to Contact the Firm",
            "description": "NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of UiPath, Inc. (NYSE: PATH), Tandem Diabetes Car\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/18/2744383/0/en/Bragar-Eagel-Squire-P-C-Reminds-Investors-That-Class-Action-Lawsuits-Have-Been-Filed-Against-UiPath-Tandem-and-Leslie-s-and-Encourages-Investors-to-Contact-the-Firm.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/29481954-f2ff-4756-b5a9-d982a6497bd0",
            "publishedAt": "2023-09-18T01:00:00Z",
            "content": "NEW YORK, Sept. 17, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel &amp; Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf o\u2026 [+5311 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Bragar Eagel & Squire",
            "title": "Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UiPath, Tandem, and Leslie\u2019s and Encourages Investors to Contact the Firm",
            "description": "NEW YORK, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of UiPath, Inc. (NYSE: PATH), Tandem Diabetes Car\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/23/2748236/0/en/Bragar-Eagel-Squire-P-C-Reminds-Investors-That-Class-Action-Lawsuits-Have-Been-Filed-Against-UiPath-Tandem-and-Leslie-s-and-Encourages-Investors-to-Contact-the-Firm.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/29481954-f2ff-4756-b5a9-d982a6497bd0",
            "publishedAt": "2023-09-23T01:00:00Z",
            "content": "NEW YORK, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel &amp; Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf o\u2026 [+5311 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Bragar Eagel & Squire",
            "title": "Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against UiPath, Tandem, and Leslie\u2019s and Encourages Investors to Contact the Firm",
            "description": "NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of UiPath, Inc. (NYSE: PATH), Tandem Diabetes Care\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/09/2756404/0/en/Bragar-Eagel-Squire-P-C-Reminds-Investors-That-Class-Action-Lawsuits-Have-Been-Filed-Against-UiPath-Tandem-and-Leslie-s-and-Encourages-Investors-to-Contact-the-Firm.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/29481954-f2ff-4756-b5a9-d982a6497bd0",
            "publishedAt": "2023-10-09T01:00:00Z",
            "content": "NEW YORK, Oct. 08, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel &amp; Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of\u2026 [+5310 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Lifshitz Law Firm, P.C.",
            "title": "Lifshitz Law PLLC Announces Investigations of UiPath, Inc. (NYSE: PATH), Tandem Diabetes Care, Inc. (NASDAQ: TNDM), Leslie\u2019s, Inc. (NASDAQ: LESL), and PacWest Bancorp (NASDAQ: PACW)",
            "description": "NEW YORK, Sept.  23, 2023  (GLOBE NEWSWIRE) --     UiPath, Inc. (NYSE: PATH)    Lifshitz Law PLLC announces investigation into possible securities laws......",
            "url": "https://www.globenewswire.com/news-release/2023/09/23/2748253/0/en/Lifshitz-Law-PLLC-Announces-Investigations-of-UiPath-Inc-NYSE-PATH-Tandem-Diabetes-Care-Inc-NASDAQ-TNDM-Leslie-s-Inc-NASDAQ-LESL-and-PacWest-Bancorp-NASDAQ-PACW.html",
            "urlToImage": null,
            "publishedAt": "2023-09-23T23:09:00Z",
            "content": "NEW YORK, Sept. 23, 2023 (GLOBE NEWSWIRE) -- \r\nUiPath, Inc. (NYSE: PATH)\r\nLifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in con\u2026 [+5013 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Rosen Law Firm PA",
            "title": "ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TNDM",
            "description": "NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022 and November 2, 2022, both dates inclusive (the \u201cClass Pe\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/30/2752326/673/en/ROSEN-TOP-RANKED-GLOBAL-COUNSEL-Encourages-Tandem-Diabetes-Care-Inc-Investors-with-Losses-in-Excess-of-100K-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-T.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/745335af-3a3a-4fb5-84c0-fdedc9adf092",
            "publishedAt": "2023-09-30T00:33:00Z",
            "content": "NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 20\u2026 [+4717 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Rosen Law Firm PA",
            "title": "ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TNDM",
            "description": "NEW YORK, Oct. 05, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022 and November 2, 2022, both dates inclusive (the \u201cClass Per\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/05/2755856/673/en/ROSEN-RECOGNIZED-INVESTOR-COUNSEL-Encourages-Tandem-Diabetes-Care-Inc-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-TNDM.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/745335af-3a3a-4fb5-84c0-fdedc9adf092",
            "publishedAt": "2023-10-05T23:12:00Z",
            "content": "NEW YORK, Oct. 05, 2023 (GLOBE NEWSWIRE) -- \r\nWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2\u2026 [+4760 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Rosen Law Firm PA",
            "title": "ROSEN, SKILLED INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TNDM",
            "description": "NEW YORK, Sept. 23, 2023 (GLOBE NEWSWIRE) -- WHY:\u00a0Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022 and November 2, 2022, both dates inclusive (the \u201cClass Pe\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/23/2748244/673/en/ROSEN-SKILLED-INVESTOR-COUNSEL-Encourages-Tandem-Diabetes-Care-Inc-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-TNDM.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/745335af-3a3a-4fb5-84c0-fdedc9adf092",
            "publishedAt": "2023-09-23T12:42:00Z",
            "content": "NEW YORK, Sept. 23, 2023 (GLOBE NEWSWIRE) -- \r\nWHY:\u00a0Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, \u2026 [+4720 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Rosen Law Firm PA",
            "title": "ROSEN, A LONGSTANDING LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TNDM",
            "description": "NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022 and November 2, 2022, both dates inclusive (the \u201cClass Per\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/10/2757882/673/en/ROSEN-A-LONGSTANDING-LAW-FIRM-Encourages-Tandem-Diabetes-Care-Inc-Investors-with-Losses-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-TNDM.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/745335af-3a3a-4fb5-84c0-fdedc9adf092",
            "publishedAt": "2023-10-10T19:25:00Z",
            "content": "NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) -- \r\nWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2\u2026 [+4759 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Bragar Eagel & Squire",
            "title": "Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tandem, Leslie\u2019s, and PacWest and Encourages Investors to Contact the Firm",
            "description": "NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM), Lesl\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/04/2754269/0/en/Bragar-Eagel-Squire-P-C-Reminds-Investors-That-Class-Action-Lawsuits-Have-Been-Filed-Against-Tandem-Leslie-s-and-PacWest-and-Encourages-Investors-to-Contact-the-Firm.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/29481954-f2ff-4756-b5a9-d982a6497bd0",
            "publishedAt": "2023-10-04T01:00:00Z",
            "content": "NEW YORK, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel &amp; Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of\u2026 [+5107 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Bragar Eagel & Squire",
            "title": "Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tandem, Leslie\u2019s, and PacWest and Encourages Investors to Contact the Firm",
            "description": "NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM), Les\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/29/2751714/0/en/Bragar-Eagel-Squire-P-C-Reminds-Investors-That-Class-Action-Lawsuits-Have-Been-Filed-Against-Tandem-Leslie-s-and-PacWest-and-Encourages-Investors-to-Contact-the-Firm.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/29481954-f2ff-4756-b5a9-d982a6497bd0",
            "publishedAt": "2023-09-29T01:00:00Z",
            "content": "NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel &amp; Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf o\u2026 [+5108 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Rosen Law Firm PA",
            "title": "ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action \u2013 TNDM",
            "description": "NEW YORK, Sept. 15, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022 and N\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/15/2744278/673/en/ROSEN-GLOBAL-INVESTOR-COUNSEL-Encourages-Tandem-Diabetes-Care-Inc-Investors-to-Secure-Counsel-Before-Important-Deadline-in-Securities-Class-Action-TNDM.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/745335af-3a3a-4fb5-84c0-fdedc9adf092",
            "publishedAt": "2023-09-15T22:26:00Z",
            "content": "NEW YORK, Sept. 15, 2023 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Tandem Dia\u2026 [+4711 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "TNDM Investors Have Opportunity to Lead Tandem Diabetes Care, Inc. Securities Fraud Lawsuit",
            "description": "LOS ANGELES, Sept. 27, 2023 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Tandem Diabetes Care, Inc. (\"Tandem\" or the \"Company\") (NA\u2026",
            "url": "https://www.prnewswire.com/news-releases/tndm-investors-have-opportunity-to-lead-tandem-diabetes-care-inc-securities-fraud-lawsuit-301940791.html",
            "urlToImage": null,
            "publishedAt": "2023-09-27T20:13:00Z",
            "content": "LOS ANGELES, Sept. 27, 2023 /PRNewswire/ --\u00a0The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit agains\u2026 [+2003 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "Dexcom Solidifies Global Leadership in Continuous Glucose Monitoring With New Clinical Data Presented at EASD",
            "description": "(marketscreener.com) \n\nCOMISAIR study is now the longest prospective real-world CGM study ever conducted, demonstrating significant and continued HbA1c reduction for patients using real-time CGM over seven years.1\n\n\n\nNew data shows the Dexcom ONE CGM system d\u2026",
            "url": "https://www.marketscreener.com/quote/stock/DEXCOM-INC-9115/news/Dexcom-Solidifies-Global-Leadership-in-Continuous-Glucose-Monitoring-With-New-Clinical-Data-Presente-44961043/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-10-02T06:01:02Z",
            "content": "COMISAIR study is now the longest prospective real-world CGM study ever conducted, demonstrating significant and continued HbA1c reduction for patients using real-time CGM over seven years.1\r\nNew dat\u2026 [+9204 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "DataHorizzon Research",
            "title": "Infusion Pumps Market To Reach USD 31.1 Billion By 2032 CAGR: 9.4%. Report By DataHorizzon Research",
            "description": "According to DataHorizzon Research, The infusion pumps market size was valued at USD 12.8 Billion in 2022 and is expected to have a market size of USD 31.1 Billion by 2032 with a CAGR of 9.4%. According to DataHorizzon Research, The infusion pumps market size\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/29/2751706/0/en/Infusion-Pumps-Market-To-Reach-USD-31-1-Billion-By-2032-CAGR-9-4-Report-By-DataHorizzon-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/ee0903f0-279f-4537-8a89-666461d3d324",
            "publishedAt": "2023-09-29T00:20:00Z",
            "content": "Fort Collins, Colorado, Sept. 28, 2023 (GLOBE NEWSWIRE) -- DataHorizzon Research Published a report titled, \"Infusion Pumps Market Size, Growth, Share, Statistics Report, By Type (Volumetric Pumps, S\u2026 [+8472 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Major Players in the Insulin Patch Pumps Global Market to 2030 Include Callnovo, Medtronic, Ypsomed, Sanofi and More",
            "description": "Dublin, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The \"Insulin Patch Pumps Global Market Report 2023\" report has been added to ResearchAndMarkets.com's offering.Major players in the insulin patch pumps market are Cellnovo, Insulet Corporation, Medtronic PLC., Tandem\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/26/2749269/28124/en/Major-Players-in-the-Insulin-Patch-Pumps-Global-Market-to-2030-Include-Callnovo-Medtronic-Ypsomed-Sanofi-and-More.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-09-26T10:03:00Z",
            "content": "Dublin, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The \"Insulin Patch Pumps Global Market Report 2023\" report has been added to ResearchAndMarkets.com's offering.\r\nMajor players in the insulin patch pumps ma\u2026 [+5076 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Global Diabetes Epidemic: Unprecedented Economic Burden of $966 Billion in 2021 Underscores Urgency for Innovative Therapeutics and Diagnostics",
            "description": "Dublin, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The \"Global Markets for Diabetes Therapeutics and Diagnostics\" report has been added to ResearchAndMarkets.com's offering.",
            "url": "https://www.globenewswire.com/news-release/2023/09/18/2744679/28124/en/Global-Diabetes-Epidemic-Unprecedented-Economic-Burden-of-966-Billion-in-2021-Underscores-Urgency-for-Innovative-Therapeutics-and-Diagnostics.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-09-18T11:38:00Z",
            "content": "Dublin, Sept. 18, 2023 (GLOBE NEWSWIRE) -- The \"Global Markets for Diabetes Therapeutics and Diagnostics\" report has been added to ResearchAndMarkets.com's offering.\r\nThe latest market analysis prese\u2026 [+7219 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "MarketResearch.biz",
            "title": "Insulin Pumps Market to Reach USD 12.0 Billion in 2032 Owing to Rising Prevalence of Diabetes and Advancements in Insulin Pumps",
            "description": "Marketresearch.biz reports that the global insulin pumps market is rapidly growing in revenue, driven by rising diabetes prevalence, technological advancements in insulin pump devices, and increasing awareness of the convenience of continuous insulin delivery\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/18/2744677/0/en/Insulin-Pumps-Market-to-Reach-USD-12-0-Billion-in-2032-Owing-to-Rising-Prevalence-of-Diabetes-and-Advancements-in-Insulin-Pumps.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/c3dd3252-df77-479a-b7c4-80d9485ae7b0",
            "publishedAt": "2023-09-18T11:34:00Z",
            "content": "New York, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Global insulin pumps market size was USD 5.3 Billion in 2022 and is expected to reach USD 12.0 billion in 2032 and register a revenue CAGR of 8.7% between\u2026 [+18755 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Research and Markets",
            "title": "Technological Innovations and Advances in Nanotechnology Boost the Efficiency of Abdominal Pads in Wound Care",
            "description": "Dublin, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The \"Abdominal Pads Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Sterile, Non-Sterile), By Application (Surgical Wounds, Chronic Wounds, Burns, Others), By End \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/09/2756490/28124/en/Technological-Innovations-and-Advances-in-Nanotechnology-Boost-the-Efficiency-of-Abdominal-Pads-in-Wound-Care.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/908fb457-7f8e-4a08-9081-5565e3dfb3d7",
            "publishedAt": "2023-10-09T08:48:00Z",
            "content": "Dublin, Oct. 09, 2023 (GLOBE NEWSWIRE) -- The \"Abdominal Pads Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Type (Sterile, Non-Sterile), By Applicati\u2026 [+5674 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM",
            "description": "NEW YORK, Sept. 29, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (\"Tandem\" or the \"Company\") (NASDAQ: TNDM). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com \u2026",
            "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-tandem-diabetes-care-inc---tndm-301943362.html",
            "urlToImage": "https://mma.prnewswire.com/media/1486339/Pomerantz_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-29T21:03:00Z",
            "content": "NEW YORK, Sept. 29, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (\"Tandem\" or the \"Company\") (NASDAQ:\u00a0TNDM). Such investors are advi\u2026 [+1774 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Vantage Market Research",
            "title": "By 2030, Demand for Infusion Pump Market Will Surpass $27383.94 Million at 8.50% CAGR Growth | Vantage Market Research",
            "description": "WASHINGTON, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The Infusion Pump Market is valued at USD 14257.99 Million in 2022 and is expected to reach USD 27383.94 Million by 2030 at a CAGR of 8.50% over the forecast period 2023-2030.",
            "url": "https://www.globenewswire.com/news-release/2023/09/26/2749378/0/en/By-2030-Demand-for-Infusion-Pump-Market-Will-Surpass-27383-94-Million-at-8-50-CAGR-Growth-Vantage-Market-Research.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/b992ad70-52a5-4308-9ec3-ec32ebfecaee",
            "publishedAt": "2023-09-26T11:35:00Z",
            "content": "WASHINGTON, Sept. 26, 2023 (GLOBE NEWSWIRE) -- The Infusion Pump Market is valued at USD 14257.99 Million in 2022 and is expected to reach USD 27383.94 Million by 2030 at a CAGR of 8.50% over the for\u2026 [+10074 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PR Newswire UK"
            },
            "author": null,
            "title": "Insulin Pump Market Size is Expected to Reach USD 12.18 Billion by 2028, With a 13.64% CAGR by 2028 | Brandessence Market Research",
            "description": "LONDON, Sept. 24, 2023 /PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), \"Insulin Pump Market By Product Type, By End User, Industry Analysis, Trends, And Forecast 2028\". The Insulin Pump Market was valued at\u2026",
            "url": "https://www.prnewswire.co.uk/news-releases/insulin-pump-market-size-is-expected-to-reach-usd-12-18-billion-by-2028--with-a-13-64-cagr-by-2028--brandessence-market-research-301937101.html",
            "urlToImage": "https://mma.prnewswire.com/media/1392316/4254672/BEMR_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-25T03:38:00Z",
            "content": "LONDON, Sept. 24, 2023 /PRNewswire/ --\u00a0According to a comprehensive research report by\u00a0Brandessence Market Research (BMRC), \"Insulin Pump Market By Product Type, By End User, Industry Analysis, Trend\u2026 [+11006 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "Insulin Pump Market Size is Expected to Reach USD 12.18 Billion by 2028, With a 13.64% CAGR by 2028 | Brandessence Market Research",
            "description": "LONDON, Sept. 24, 2023 /PRNewswire/ -- According to a comprehensive research report by Brandessence Market Research (BMRC), \"Insulin Pump Market By Product Type, By End User, Industry Analysis, Trends, And Forecast 2028\". The Insulin Pump Market was valued at\u2026",
            "url": "https://www.prnewswire.com/news-releases/insulin-pump-market-size-is-expected-to-reach-usd-12-18-billion-by-2028--with-a-13-64-cagr-by-2028--brandessence-market-research-301937087.html",
            "urlToImage": "https://mma.prnewswire.com/media/1392316/4254672/BEMR_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-25T03:23:00Z",
            "content": "LONDON, Sept. 24, 2023 /PRNewswire/ --\u00a0According to a comprehensive research report by\u00a0Brandessence Market Research (BMRC), \"Insulin Pump Market By Product Type, By End User, Industry Analysis, Trend\u2026 [+10978 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Marketscreener.com"
            },
            "author": "Business Wire",
            "title": "DocGo Partners with Main Line Health in Philadelphia to Provide Medical Transportation, and Agrees to Collaborate on Remote Patient Monitoring Initiatives",
            "description": "(marketscreener.com) \nNew expansion solidifies Ambulnz by DocGo\u2019s position as one of the largest ambulance providers in Philadelphia\n\nhttps://www.marketscreener.com/quote/stock/DOCGO-INC-129164811/news/DocGo-Partners-with-Main-Line-Health-in-Philadelphia-to-P\u2026",
            "url": "https://www.marketscreener.com/quote/stock/DOCGO-INC-129164811/news/DocGo-Partners-with-Main-Line-Health-in-Philadelphia-to-Provide-Medical-Transportation-and-Agrees-t-44981456/",
            "urlToImage": "https://www.marketscreener.com/images/twitter_MS_fdblanc.png",
            "publishedAt": "2023-10-04T11:36:01Z",
            "content": "New expansion solidifies Ambulnz by DocGos position as one of the largest ambulance providers in Philadelphia\r\nDocGo Inc. (Nasdaq:DCGO), a leading provider of technology-enabled mobile health service\u2026 [+9478 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "National Association of Specialty Pharmacy (NASP)",
            "title": "National Association of Specialty Pharmacy (NASP) Welcomes New Board Chairman, New Board Members, and Congratulates Award Winners at its Record-Breaking 2023 Annual Meeting & Expo",
            "description": "The National Association of Specialty Pharmacy (NASP) welcomes five new board members and announces Industry Award, Poster, and Scholarship winners at its record-breaking 2023 Annual Meeting & Expo in Grapevine, TX. The National Association of Specialty Pharm\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/21/2747620/0/en/National-Association-of-Specialty-Pharmacy-NASP-Welcomes-New-Board-Chairman-New-Board-Members-and-Congratulates-Award-Winners-at-its-Record-Breaking-2023-Annual-Meeting-Expo.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/3005cf65-d499-4db3-9b30-d3563e68050e",
            "publishedAt": "2023-09-21T19:13:00Z",
            "content": "Washington, D.C., Sept. 21, 2023 (GLOBE NEWSWIRE) -- This week NASP Immediate Past Board Chairman, Kyle Skiermont, PharmD, announced the following:\r\nScott Guisinger, Vice President Pharmacy (Northeas\u2026 [+6404 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Market.Us",
            "title": "Connected Drug Delivery Devices Market Set to Reach USD 2,980.9 Million by 2032, Fueled by Personalized Medicine Trends",
            "description": "The rising popularity of connected drug delivery devices is driving the growth in demand for home healthcare. These devices provide convenience and user-friendliness, making them a preferred choice for elderly individuals who wish to manage their medical cond\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/09/2756786/0/en/Connected-Drug-Delivery-Devices-Market-Set-to-Reach-USD-2-980-9-Million-by-2032-Fueled-by-Personalized-Medicine-Trends.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/80497cfc-1ece-42b4-9027-27841cdcb680",
            "publishedAt": "2023-10-09T13:38:00Z",
            "content": "New York, Oct. 09, 2023 (GLOBE NEWSWIRE) -- According to a recent report by Market.us, the Global Connected Drug Delivery Devices Market size is expected to be worth around USD 2,980.9 Million by 203\u2026 [+13461 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "TOP RANKED ROSEN LAW FIRM Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TNDM",
            "description": "NEW YORK, Sept. 14, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022 and Novem\u2026",
            "url": "https://www.prnewswire.com/news-releases/top-ranked-rosen-law-firm-encourages-tandem-diabetes-care-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action--tndm-301928530.html",
            "urlToImage": "https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-14T23:49:00Z",
            "content": "NEW YORK, Sept. 14, 2023 /PRNewswire/ --\r\nWHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Tandem Diabet\u2026 [+4778 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Market.Us",
            "title": "Infusion Pump Market Projections: Anticipated Expansion to Reach USD 22.6 billion by 2032 || Market.us",
            "description": "The market is experiencing significant growth due to the rising incidence of chronic diseases. Furthermore, ongoing advancements in drug delivery technologies are expected to drive further expansion in the market. The market is experiencing significant growth\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/04/2754604/0/en/Infusion-Pump-Market-Projections-Anticipated-Expansion-to-Reach-USD-22-6-billion-by-2032-Market-us.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/80497cfc-1ece-42b4-9027-27841cdcb680",
            "publishedAt": "2023-10-04T12:47:00Z",
            "content": "New York, Oct. 04, 2023 (GLOBE NEWSWIRE) -- According to Market.us, the Infusion Pump Market size is expected to be worth around USD 22.6 Billion by 2032 from USD 12.1 Billion in 2022, growing at a C\u2026 [+13003 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "ROSEN, A LONGSTANDING LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - TNDM",
            "description": "NEW YORK, Sept. 28, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022 and November 2, 2022, both dates inclusive (the \"Class Period\u2026",
            "url": "https://www.prnewswire.com/news-releases/rosen-a-longstanding-law-firm-encourages-tandem-diabetes-care-inc-investors-with-losses-in-excess-of-100k-to-secure-counsel-before-important-deadline-in-securities-class-action--tndm-301942171.html",
            "urlToImage": "https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-28T20:03:00Z",
            "content": "NEW YORK, Sept. 28, 2023 /PRNewswire/ --\u00a0\r\nWHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022\u2026 [+4819 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Law Offices of Frank R. Cruz",
            "title": "DEADLINE ALERT for DFS, PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders",
            "description": "LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.\u00a0 Investors have until the deadlines listed below\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/10/2757804/0/en/DEADLINE-ALERT-for-DFS-PATH-TNDM-and-LESL-The-Law-Offices-of-Frank-R-Cruz-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/778ea178-25d1-48a3-9141-a162814899d4",
            "publishedAt": "2023-10-10T16:12:00Z",
            "content": "LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded\u2026 [+6894 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Law Offices of Frank R. Cruz",
            "title": "DEADLINE ALERT for DFS, PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders",
            "description": "LOS ANGELES, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.\u00a0 Investors have until the deadlines listed belo\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/28/2751489/0/en/DEADLINE-ALERT-for-DFS-PATH-TNDM-and-LESL-The-Law-Offices-of-Frank-R-Cruz-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/778ea178-25d1-48a3-9141-a162814899d4",
            "publishedAt": "2023-09-28T16:12:00Z",
            "content": "LOS ANGELES, Sept. 28, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-trade\u2026 [+6895 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Law Offices of Frank R. Cruz",
            "title": "DEADLINE ALERT for DFS, PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders",
            "description": "LOS ANGELES, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.\u00a0 Investors have until the deadlines listed belo\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/22/2748102/0/en/DEADLINE-ALERT-for-DFS-PATH-TNDM-and-LESL-The-Law-Offices-of-Frank-R-Cruz-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/778ea178-25d1-48a3-9141-a162814899d4",
            "publishedAt": "2023-09-22T16:16:00Z",
            "content": "LOS ANGELES, Sept. 22, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-trade\u2026 [+6895 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Law Offices of Frank R. Cruz",
            "title": "DEADLINE ALERT for DFS, PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders",
            "description": "LOS ANGELES, Sept. 15, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/15/2744187/0/en/DEADLINE-ALERT-for-DFS-PATH-TNDM-and-LESL-The-Law-Offices-of-Frank-R-Cruz-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/778ea178-25d1-48a3-9141-a162814899d4",
            "publishedAt": "2023-09-15T17:16:00Z",
            "content": "LOS ANGELES, Sept. 15, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-trade\u2026 [+6892 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "The Law Offices of Frank R. Cruz",
            "title": "DEADLINE ALERT for DFS, PATH, TNDM, and LESL: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders",
            "description": "LOS ANGELES, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/05/2755683/0/en/DEADLINE-ALERT-for-DFS-PATH-TNDM-and-LESL-The-Law-Offices-of-Frank-R-Cruz-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders.html",
            "urlToImage": "https://ml.globenewswire.com/Resource/Download/778ea178-25d1-48a3-9141-a162814899d4",
            "publishedAt": "2023-10-05T16:15:00Z",
            "content": "LOS ANGELES, Oct. 05, 2023 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded\u2026 [+6891 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Law Offices of Howard G. Smith",
            "title": "DEADLINE ALERT for TNDM, LESL, PACW, DOCN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders",
            "description": "BENSALEM, Pa., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/05/2755493/3448/en/DEADLINE-ALERT-for-TNDM-LESL-PACW-DOCN-Law-Offices-of-Howard-G-Smith-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders.html",
            "urlToImage": null,
            "publishedAt": "2023-10-05T13:30:00Z",
            "content": "BENSALEM, Pa., Oct. 05, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded\u2026 [+4633 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Law Offices of Howard G. Smith",
            "title": "DEADLINE ALERT for TNDM, LESL, PACW, DOCN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders",
            "description": "BENSALEM, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below\u2026",
            "url": "https://www.globenewswire.com/news-release/2023/09/29/2752242/3448/en/DEADLINE-ALERT-for-TNDM-LESL-PACW-DOCN-Law-Offices-of-Howard-G-Smith-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders.html",
            "urlToImage": null,
            "publishedAt": "2023-09-29T18:00:00Z",
            "content": "BENSALEM, Pa., Sept. 29, 2023 (GLOBE NEWSWIRE) -- \r\nLaw Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-tra\u2026 [+4636 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "GlobeNewswire"
            },
            "author": "Law Offices of Howard G. Smith",
            "title": "DEADLINE ALERT for TNDM, LESL, PACW, DOCN: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders",
            "description": "BENSALEM, Pa., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below \u2026",
            "url": "https://www.globenewswire.com/news-release/2023/10/13/2760003/3448/en/DEADLINE-ALERT-for-TNDM-LESL-PACW-DOCN-Law-Offices-of-Howard-G-Smith-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders.html",
            "urlToImage": null,
            "publishedAt": "2023-10-13T13:37:00Z",
            "content": "BENSALEM, Pa., Oct. 13, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded\u2026 [+4633 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM",
            "description": "NEW YORK, Sept. 13, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (\"Tandem\" or the \"Company\") (NASDAQ: TNDM). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com \u2026",
            "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-tandem-diabetes-care-inc---tndm-301926814.html",
            "urlToImage": "https://mma.prnewswire.com/media/1486339/Pomerantz_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-13T21:03:00Z",
            "content": "NEW YORK, Sept. 13, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of\u00a0\u00a0Tandem Diabetes Care, Inc. (\"Tandem\" or the \"Company\")\u00a0(NASDAQ:\u00a0TNDM).\u00a0\u00a0 Such investors are a\u2026 [+1778 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Tandem Diabetes Care, Inc. - TNDM",
            "description": "NEW YORK, Sept. 21, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (\"Tandem\" or the \"Company\") (NASDAQ: TNDM). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com \u2026",
            "url": "https://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-tandem-diabetes-care-inc---tndm-301935406.html",
            "urlToImage": "https://mma.prnewswire.com/media/1486339/Pomerantz_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-21T21:38:00Z",
            "content": "NEW YORK, Sept. 21, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (\"Tandem\" or the \"Company\") (NASDAQ: TNDM). Such investors are advi\u2026 [+1771 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "TNDM SHAREHOLDER ALERT: ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - TNDM",
            "description": "NEW YORK, Sept. 21, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 2022 and November 2, 2022, both dates inclusive (the \"Class Period\u2026",
            "url": "https://www.prnewswire.com/news-releases/tndm-shareholder-alert-rosen-a-globally-recognized-firm-encourages-tandem-diabetes-care-inc-investors-to-secure-counsel-before-important-deadline-in-securities-class-action--tndm-301935445.html",
            "urlToImage": "https://mma.prnewswire.com/media/405060/Rosen_Law_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-22T02:10:00Z",
            "content": "NEW YORK, Sept. 21, 2023 /PRNewswire/ --\u00a0\r\nWHY:\u00a0 Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) between August 3, 202\u2026 [+4826 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "TNDM INVESTOR ALERT: Tandem Diabetes Care, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit",
            "description": "SAN DIEGO, Sept. 16, 2023 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 and November 2, 2022, inclusive (the \"Class Period\") have until No\u2026",
            "url": "https://www.prnewswire.com/news-releases/tndm-investor-alert-tandem-diabetes-care-inc-investors-with-substantial-losses-have-opportunity-to-lead-class-action-lawsuit-301929649.html",
            "urlToImage": "https://mma.prnewswire.com/media/198876/robbins_geller_rudman_and_dowd_llp_logo.jpg?p=facebook",
            "publishedAt": "2023-09-16T18:20:00Z",
            "content": "SAN DIEGO, Sept. 16, 2023 /PRNewswire/ -- Robbins Geller Rudman &amp; Dowd LLP announces that purchasers or acquirers of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) securities between August 3, 2022 an\u2026 [+4176 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "PRNewswire"
            },
            "author": null,
            "title": "Revolutionary Trends in Diabetes Monitoring Devices Set to Propel Market Growth with 6.4% CAGR, Lancets and Devices Subsegment Surges at 10.3% CAGR",
            "description": "DUBLIN, Sept. 14, 2023 /PRNewswire/ -- The \"Global Markets for Diabetes Therapeutics and Diagnostics\" report has been added to ResearchAndMarkets.com's offering. The latest market analysis presents an optimistic outlook for the global Diabetes Therapeutics an\u2026",
            "url": "https://www.prnewswire.com/news-releases/revolutionary-trends-in-diabetes-monitoring-devices-set-to-propel-market-growth-with-6-4-cagr-lancets-and-devices-subsegment-surges-at-10-3-cagr-301927642.html",
            "urlToImage": "https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg?p=facebook",
            "publishedAt": "2023-09-14T15:45:00Z",
            "content": "DUBLIN, Sept. 14, 2023 /PRNewswire/ -- The \"Global Markets for Diabetes Therapeutics and Diagnostics\" report has been added to \u00a0ResearchAndMarkets.com's offering.\r\nThe latest market analysis presents\u2026 [+7611 chars]"
        },
        {
            "source": {
                "id": "financial-post",
                "name": "Financial Post"
            },
            "author": "Bloomberg News",
            "title": "A stock investor\u2019s guide to navigating weight-loss opportunities",
            "description": "Here are some of the stocks and sectors that are likely to see the biggest impact from the boom in demand for weight-loss drugs. Read on.",
            "url": "https://financialpost.com/investing/stock-investor-guide-navigating-weight-loss-opportunities",
            "urlToImage": "https://smartcdn.gprod.postmedia.digital/financialpost/wp-content/uploads/2023/09/no0920Novo.jpg",
            "publishedAt": "2023-09-20T15:12:56Z",
            "content": "Here are some of the stocks and sectors that are likely to see the biggest impact \r\nAuthor of the article:\r\nThe anti-diabetic medication Ozempic made by Danish pharmaceutical company Novo Nordisk A/S\u2026 [+12810 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "MarketWatch"
            },
            "author": "Eleanor Laise",
            "title": "The Ratings Game: These diabetes stocks, pummeled by the Ozempic craze, now look like bargains, analysts say",
            "description": "DexCom could be the first stock to break out of \u2018GLP jail,\u2019 analysts say, as market continues to punish device makers",
            "url": "https://www.marketwatch.com/story/these-diabetes-stocks-pummeled-by-the-ozempic-craze-now-look-like-bargains-analysts-say-30906b51",
            "urlToImage": "https://images.mktw.net/im-852331/social",
            "publishedAt": "2023-10-05T13:38:09Z",
            "content": "Diabetes device stocks that have been crushed in recent months by an Ozempic-fueled weight-loss drug frenzy have now been punished enough, some analysts say.\u00a0The markets enthusiasm for Novo Nordisks \u2026 [+4144 chars]"
        },
        {
            "source": {
                "id": null,
                "name": "Plos.org"
            },
            "author": "Tayane Muniz Fighera, Bet\u00e2nia Rodrigues dos Santos, Poli Mara Spritzer",
            "title": "Lean mass and associated factors in women with PCOS with different phenotypes",
            "description": "Although current evidence suggests increased risk of obesity, insulin resistance, and metabolic alterations in patients with polycystic ovary syndrome (PCOS), especially of a hyperandrogenic phenotype, the impact of each one of these variables on muscle mass \u2026",
            "url": "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0292623",
            "urlToImage": "https://journals.plos.org/plosone/article/figure/image?id=10.1371/journal.pone.0292623.g001&size=inline",
            "publishedAt": "2023-10-05T14:00:00Z",
            "content": "Abstract\r\nAlthough current evidence suggests increased risk of obesity, insulin resistance, and metabolic alterations in patients with polycystic ovary syndrome (PCOS), especially of a hyperandrogeni\u2026 [+37407 chars]"
        }
    ]
}